168 related articles for article (PubMed ID: 18622428)
1. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
2. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha.
Sethi G; Ahn KS; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Nov; 26(52):7324-32. PubMed ID: 17533369
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
Mehta VB; Besner GE
J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
[TBL] [Abstract][Full Text] [Related]
5. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium.
Sun L; Carpenter G
Oncogene; 1998 Apr; 16(16):2095-102. PubMed ID: 9572490
[TBL] [Abstract][Full Text] [Related]
7. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
Wagner S; Carpentier I; Rogov V; Kreike M; Ikeda F; Löhr F; Wu CJ; Ashwell JD; Dötsch V; Dikic I; Beyaert R
Oncogene; 2008 Jun; 27(26):3739-45. PubMed ID: 18212736
[TBL] [Abstract][Full Text] [Related]
9. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
10. LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.
Wullaert A; Verstrepen L; Van Huffel S; Adib-Conquy M; Cornelis S; Kreike M; Haegman M; El Bakkouri K; Sanders M; Verhelst K; Carpentier I; Cavaillon JM; Heyninck K; Beyaert R
J Biol Chem; 2007 Jan; 282(1):81-90. PubMed ID: 17088249
[TBL] [Abstract][Full Text] [Related]
11. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
12. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
Wang HJ; Wu ZY; Fan P; Bian JM
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
[TBL] [Abstract][Full Text] [Related]
13. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform.
Banan A; Zhang LJ; Shaikh M; Fields JZ; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2004 Apr; 309(1):356-68. PubMed ID: 14724221
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
16. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1.
Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C
Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.
Liu WK; Yen PF; Chien CY; Fann MJ; Su JY; Chou CK
Biochem J; 2004 Mar; 378(Pt 3):867-76. PubMed ID: 14653779
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells.
Häussler U; von Wichert G; Schmid RM; Keller F; Schneider G
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F808-15. PubMed ID: 15798085
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1.
Heyninck K; Kreike MM; Beyaert R
FEBS Lett; 2003 Feb; 536(1-3):135-40. PubMed ID: 12586352
[TBL] [Abstract][Full Text] [Related]
20. Expression of proangiogenic chemokine Gro 1 in low and high metastatic variants of Pam murine squamous cell carcinoma is differentially regulated by IL-1alpha, EGF and TGF-beta1 through NF-kappaB dependent and independent mechanisms.
Loukinova E; Chen Z; Van Waes C; Dong G
Int J Cancer; 2001 Dec; 94(5):637-44. PubMed ID: 11745457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
